0001140361-23-006111.txt : 20230210 0001140361-23-006111.hdr.sgml : 20230210 20230210203447 ACCESSION NUMBER: 0001140361-23-006111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230208 FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Griffin Jonathan Harrison CENTRAL INDEX KEY: 0001907718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13648 FILM NUMBER: 23614257 MAIL ADDRESS: STREET 1: 52 SUNRISE PARK ROAD CITY: NEW HAMPTON STATE: NY ZIP: 10958 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BALCHEM CORP CENTRAL INDEX KEY: 0000009326 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 132578432 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 BUSINESS PHONE: (845) 326-5600 MAIL ADDRESS: STREET 1: 5 PARAGON DRIVE CITY: MONTVALE STATE: NJ ZIP: 07645 4 1 form4.xml X0306 4 2023-02-08 0000009326 BALCHEM CORP BCPC 0001907718 Griffin Jonathan Harrison C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE NJ 07645 true SVP & GM, Animal Nutrition Common Stock 2023-02-08 4 A 0 720 0 A 9201 D Common Stock 2023-02-08 4 A 0 2279 0 A 11480 D Common Stock 2023-02-08 4 F 0 758 138.09 D 10722 D Stock Option 138.09 2023-02-08 4 A 0 2500 0 A 2033-02-08 Common Stock 2500 2500 D Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Includes acquisition of shares under the Balchem Corporation 401(k) plan. Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2020-2022 performance period. 758 of the 2,279 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Exhibit 24 - Power of Attorney is attached. /s/ Travis Larsen, Attorney in Fact for Jonathan Harrison Griffin 2023-02-10 EX-24 2 brhc10048060_ex24.htm EXHIBIT 24
Exhibit 24

POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS

The undersigned hereby constitutes and appoints Hatsuki Miyata and Travis Larsen or each individual currently serving as Balchem Corporation’s General Counsel, Secretary, Assistant General Counsel or Assistant Secretary, each, individually, with full power of substitution, as the undersigned’s true and lawful attorney-in-fact to:


 (1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC;


(2)
prepare, execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Balchem Corporation (the “Company”), Forms 3, 4, and 5 or any other required forms, including any amendments to such forms, as appropriate, in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;


(3)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or any other required forms, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and


(4)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney for Section 16 Reporting Obligations shall be in such form and shall contain such terms and conditions as such attorneys-in-fact may approve in such attorneys-in-fact’s discretion.

The undersigned hereby grants to such attorneys-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or such attorneys-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to either of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney for Section 16 Reporting Obligations to be effective as of the date of signature set forth below.

 
/s/ Jonathan Griffin
 
Jonathan H. Griffin
 
Sep 22, 2022